Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Personalis Inc | 8 | 1 | 0 | 0 | €3.19 | €3.26 | 2.274% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €7.13 | €26.25 | 267.904% |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.50 | - | - |
| XOMA Corp. | 8 | 0 | 0 | 0 | €22.20 | €68.51 | 208.600% |
| Precision BioSciences Inc | 9 | 0 | 0 | 0 | €0.35 | €10.38 | 2881.839% |
| aTyr Pharma Inc | 1 | 0 | 0 | 0 | €1.76 | €10.00 | 468.182% |
| Achieve Life Sciences Inc. | 1 | 0 | 0 | 0 | €4.43 | - | - |
| Taro Pharmaceutical Industries Ltd | 10 | 0 | 0 | 0 | €40.00 | - | - |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €5.50 | €19.50 | 254.841% |
| G1 Therapeutics | 20 | 1 | 0 | 0 | €3.65 | €11.03 | 202.103% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €9.25 | €10.00 | 8.108% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.49 | €4.63 | 85.924% |
| Roche Holding AG ADR | 3 | 3 | 0 | 1 | €37.32 | €38.00 | 1.827% |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €24.61 | €38.62 | 56.941% |
| Novo Nordisk A/S ADR | 20 | 1 | 0 | 0 | €117.00 | €144.02 | 23.093% |
| Twist Bioscience Corp | 11 | 1 | 0 | 1 | €39.36 | €41.65 | 5.812% |
| Cocrystal Pharma Inc. | 7 | 0 | 0 | 0 | €1.68 | €9.25 | 450.833% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €88.58 | - | - |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €2.72 | €6.45 | 137.665% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €42.80 | - | - |
| Icon plc | 24 | 0 | 0 | 0 | €290.80 | €326.21 | 12.177% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €4.42 | - | - |
| Amgen Inc. | 25 | 0 | 0 | 0 | €305.95 | €304.65 | -0.426% |
| Faron Pharmaceuticals Oy | 2 | 1 | 0 | 0 | €1.91 | €6.15 | 221.653% |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.63 | - | - |